Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Mar'25
Sep'24
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 23.49% vs 33.65% in Mar 2025
Standalone Net Profit
Growth in half year ended Sep 2025 is 20.73% vs 45.56% in Mar 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 20.61% vs 43.48% in Mar 2025
Interest
Growth in half year ended Sep 2025 is -100.00% vs -50.00% in Mar 2025
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Mar 2025
Compare Half Yearly Results Of Medistep Health. With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
35.07
21.07
14.00
66.45%
Other Operating Income
0.00
0.00
0.00
Total Operating income
35.07
21.07
14.00
66.45%
Raw Material Cost
7.15
17.12
-9.97
-58.24%
Purchase of Finished goods
25.92
0.00
25.92
(Increase) / Decrease In Stocks
-2.42
-1.48
-0.94
-63.51%
Employee Cost
0.13
2.92
-2.79
-95.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.32
1.08
-0.76
-70.37%
Total Expenditure (Excl Depreciation)
31.09
19.65
11.44
58.22%
Operating Profit (PBDIT) excl Other Income
3.98
1.42
2.56
180.28%
Other Income
0.00
1.36
-1.36
-100.00%
Operating Profit (PBDIT)
3.98
2.78
1.20
43.17%
Interest
0.00
0.93
-0.93
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
3.98
1.85
2.13
115.14%
Depreciation
0.01
1.15
-1.14
-99.13%
Profit Before Tax
3.97
0.69
3.28
475.36%
Tax
1.00
0.00
1.00
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2.97
0.69
2.28
330.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2.97
0.69
2.28
330.43%
Equity Capital
14.21
30.85
-16.64
-53.94%
Face Value
10.00
2.00
0.00
Reserves
20.60
0.00
20.60
Earnings per share (EPS)
2.09
0.04
2.05
5,125.00%
Diluted Earnings per share
2.61
0.04
2.57
6,425.00%
Operating Profit Margin (Excl OI)
11.35%
6.74%
0.00
4.61%
Gross Profit Margin
11.35%
8.78%
0.00
2.57%
PAT Margin
8.47%
3.27%
0.00
5.20%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 35.07 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 23.49% vs 33.65% in Mar 2025
Half Yearly - Standalone Net Profit
Standalone Net Profit 2.97 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 20.73% vs 45.56% in Mar 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.98 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 20.61% vs 43.48% in Mar 2025
Half Yearly - Interest
No Interest in the last few periods
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.35%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
